News tagged with treatment failure

Related topics: treatment · patients · drug resistance

FDA approves Procysbi for nephropathic cystinosis

(HealthDay)—Procysbi (cysteamine bitartrate) delayed-release capsules have been approved by the U.S. Food and Drug Administration to treat nephropathic cystinosis in children (6 years and up) and adults. Since it is intended ...

May 02, 2013
popularity0 comments 0

FDA reports Samsca may cause liver damage

(HealthDay)—After reviewing data from recent large clinical trials, the U.S. Food and Drug Administration has determined that Samsca (tolvaptan) should not be used for longer than 30 days and should not be used at all by ...

May 02, 2013
popularity0 comments 0

Subscribe to rss feed